Delivery Order SPE2DB20D1051-SPE2DB24FD6MC
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,932.75 firm-fixed-price delivery order is for the supply of Lidocaine 5% Patch 30s, a medical product used for pain relief. The contract has an ultimate completion date of October 30, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award, valued at $4,442.20, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of Lidocaine 5% Patches. It is a firm-fixed-price contract with a completion date of January 12, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,729.60 firm fixed-price delivery order is for Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patches, with a ceiling value of $8,124.92 and a completion date of January 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- This federal contract award, valued at $1,243.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% patches, with an ultimate completion date of April 26, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Lidocaine 5% Patch 30S. The contract, valued at $12,422.33, has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patch 30s. The award, valued at $2,182.99, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of March 11, 2024. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $13,111.70, is a Delivery Order for the provision of Lidocaine 5% Patches. The award has a completion date of May 3, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lidocaine 5% Patch 30s medical supplies. The contract, valued at $43,446.25, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary contracting agency for this award. The contract has an ultimate completion date of December 20, 2023, and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside designation, indicating...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Lidocaine 5% Patches. The contract, valued at $8,137.72, is a Firm Fixed Price Delivery Order with a completion date of June 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD6MCDelivery Order
This federal contract award, valued at $1,236.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is for the delivery of Lidocaine 5% Patch 30s, a medical product, with a completion date of December 29, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type, and there was no set-aside designation used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award is likely one of the many delivery orders placed under that larger IDC mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/28/23 |